Expression of Lea in gastric cancer cell lines depends on FUT3 expression regulated by promoter methylation

Cancer Letters

Volumn 242, Issue 2, 2006, Pages 191-197

  Serpa, Jacinta ^a   Mesquita, Patrícia ^a   Mendes, Nuno ^a   Oliveira, Carla ^a   Almeida, Raquel ^a   Santos Silva, Filipe ^a,b   Reis, Celso A ^a,b   LePendu, Jacques ^c   David, Leonor ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c INSTITUT DE BIOLOGIE   (France)

Author keywords

Fucosyltransferase; FUT3; Gastric carcinoma; Lewis antigens; Methylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 3; GLYCOPROTEIN; GLYCOPROTEIN GP 220; UNCLASSIFIED DRUG; AZACITIDINE; DRUG DERIVATIVE; GALACTOSIDE 3(4) LEVO FUCOSYLTRANSFERASE; GALACTOSIDE 3(4)-L-FUCOSYLTRANSFERASE; LUCIFERASE; PRIMER DNA; TUMOR ANTIGEN;

ARTICLE; BLOOD GROUP LEWIS SYSTEM; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METHYLATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; BIOSYNTHESIS; CHEMISTRY; DNA METHYLATION; GENE EXPRESSION REGULATION; METABOLISM; PLASMID; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL LINE;

ANTIGENS, NEOPLASM; AZACITIDINE; CELL LINE, TUMOR; DNA METHYLATION; DNA PRIMERS; FUCOSYLTRANSFERASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUCIFERASES; PLASMIDS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 33749246714     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.11.009     Document Type: Article

References (36)

1. Kokowska-Latallo J.F., Larsen R.D., Nair R.P., and Lowe J.B. A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the lewis blood group alpha (1,3/1,4) fucosyltransferase. Genes Dev. 4 (1990) 1288-1303
2. Pykäri M., Toivonen S., Natunen J., Niemela R., Salminen H., Aitio O., et al. The acceptor and site specificity of α3-fucosyltransferase V. J. Biol. Chem. 275 51 (2000) 40057-40063
3. Nguyen A.T., Holmes E.H., Whitaker J.M., Ho S., Shetterly S., and Macher B.A. Human alpha1,3/4-fucosyltransferases. I. Identification of amino acids involved in acceptor substrate binding by site-directed mutagenesis. J. Biol. Chem. 273 39 (1998) 25244-25249
4. Xu Z., Vo L., and Macher B.A. Structure-function analysis of human alpha1,3-fucosyltransferase. Amino acids involved in acceptor substrate specificity. J. Biol. Chem. 271 15 (1996) 8818-8823
5. Legault D.J., Kelly R.J., Natsuka Y., and Lowe J.B. Human α(1,3/1,4) fucosyltransferases discriminate between different oligosaccharide acceptor substrates through a discrete peptide fragment. J. Biol. Chem. 270 36 (1995) 20987-20996
6. de Vries T., Srnka C.A., Palcic M.M., Swiedler S.T., van den Eijnden D.H., and Macher B.A. Acceptor specificity of different lenght constructs of human recombinant α1,3/4-fucosyltransferases. J. Biol. Chem. 270 15 (1994) 8712-8722
7. Narimatsu H. Recent progress in molecular cloning of glycosyltransferases genes of eukaryotes. Microbiol. Immunol. 38 7 (1994) 489-504
8. Oriol R., LePendu J., and Mollicone R. Genetics of ABO, H, Lewis, X and related antigens. Vox Sang. 51 3 (1986) 161-171
9. LePendu J. Histo-blood group antigen and human milk oligosaccharides: genetic polymorphism and risk of infectious diseases. Adv. Exp. Med. Biol. 554 (2004) 135-143
10. Ziegler T., Jacobsohn N., and Funfstuck R. Correlation between blood group phenotype and virulence properties of Escherichia coli in patients with chronic urinary tract infection. Int. J. Antimicrob. Agents 24 1 (2004) 70-75
11. Kudo T., Kaneko M., Iwasaki H., Togayachi A., Nishihara S., Abe K., et al. Normal embryonic and germ cell development in mice lacking alpha 1,3-fucosyltransferase IX (Fut9) which show disappearance of stage-specific embryonic antigen 1. Mol. Cell Biol. 24 10 (2004) 4221-4228
12. Aplin J.D. Adhesion molecules in implantation. Rev. Reprod. 2 2 (1997) 84-93
13. Schenkel-Brunner H. Human Blood Group (1995), Springer, Berlin
14. Lowe J.B. Glycosylation in the control of selectin counter-receptor structure and function. Immunol. Rev. 186 (2002) 19-36
15. Mannori G., Crottet P., Cecconi O., Hanasaki K., Aruffo A., Nelson R.M., et al. Differential colon cancer cell adhesion to E-, P- and L-selectin: role of mucin-type glycoproteins. Cancer Res. 55 (1995) 4425-4431
16. Ho J.J.L., and Kim Y.S. Do mucins promote tumor cell metastasis?. Int. J. Oncol. 7 (1995) 913-926
17. Varki A. Selectin ligands. Proc. Natl Acad. Sci. USA 90 (1994) 7390-7397
18. Phillips M.L., Nudelman E.D., Gaeta F.C., Perez M., Singhal A.K., Hakomori S., et al. ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex. Science 250 (1990) 1130-1132
19. x expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology 114 (1998) 462-470
20. Nakamori S., Kameyama M., Imaoka S., Furukawa H., Ishikawa O., Sasaki Y., et al. Involvement of carbohydrate antigen sialyl Lewis (x) in colorectal cancer metastasis. Dis. Colon Rectum 40 4 (1997) 420-431
21. Saito K., Fujii Y., Kawakami S., Hayashi T., Arisawa C., Koga F., et al. Increased expression of sialyl-Lewis A correlates with poor survival in upper urinary tract urothelial cancer patients. Anticancer Res. 23 4 (2003) 3441-3446
22. Nakamori S., Kameyama M., Imaoka S., Furukawa H., Ishikawa O., Sasaki Y., et al. Increased expression of sialyl Lewis x antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res. 53 (1993) 3632-3637
23. Gärtner F., David L., Seruca R., Machado J.C., and Sobrinho-Simões M. Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice. Virchows Arch. 428 2 (1996) 91-98
24. Young Jr. W.W., Portoukalian J., and Hakomori S. Two monoclonal anticarbohydrate antibodies directed to glycosphingolipid with a lacto-N-glycosyl type II chain. J. Biol. Chem. 256 (1981) 10967-10972
25. Morais V.A., Serpa J., Palma A.S., Costa T., Maranga L., and Costa J. Expression and characterization of recombinant human alpha-3/4-fucosyltransferase III from Spodoptera frugiperda (Sf9) and Trichoplusia ni (Tn) cells using the baculovirus expression system. Biochem. J. 353 3 (2001) 719-725
26. Syrbe U., Jennrich S., Schottelius A., Richter A., Radbruch A., and Hamann A. Differential regulation of P-selectin ligand expression in naive versus memory CD4+T cells: evidence for epigenetic regulation of involved glycosyltransferases genes. Blood 104 10 (2004) 3243-3248
27. Dabelsteen E., and Gao S. ABO blood-group antigens in oral cancer. J. Dent. Res. 84 1 (2005) 21-28
28. Gao S., Worm J., Guldberg P., Eiberg H., Krogdahl A., Liu C.J., et al. Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int. J. Cancer 109 2 (2004) 230-237
29. Iwamato S., Withers D.A., Handa K., and Hakomori S. Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NY-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter. Glycoconj. J. 16 10 (1999) 659-666
30. Kominato Y., Hata Y., Takizawa H., Tsuchiya T., Tsukada J., and Yamamoto F. Expression of human histo-blood group ABO genes is dependent upon DNA methylation of the promoter region. J. Biol. Chem. 274 24 (1999) 37240-37250
31. Kaneda A., Tsukamoto T., Takamura-Enya T., Watanabe N., Kaminishi M., Sugimura T., et al. Frequent hypomethylation in multiple promoter CpG island is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci. 95 1 (2003) 58-64
32. Cravo M., Pinto R., Fidalgo P., Chaves P., Gloria L., Nobre-Leitao C., et al. Global DNA hypomethylation occurs in the early stages of intestinal type gastric carcinoma. Gut 39 3 (1996) 434-438
33. Frigola J., Solé X., Paz M.F., Moreno V., Esteller M., Capella G., et al. Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum. Mol. Genet. 14 2 (2005) 319-326
34. Bariol C., Suter C., Cheong K., Ku S.L., Meagher A., Hawkins N., et al. The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am. J. Pathol. 162 4 (2003) 1361-1371
35. Goelz S.E., Vogelstein B., Hamilton S.R., and Feinberg A.P. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 228 (1985) 187-191
36. Eden A., Gaudet F., Waghmare A., and Jaenisch R. Chromosomal instability in tumors by DNA hypomethylation. Science 300 (2003) 455